Abstract
Objective
Methods
Results
Conclusion
ACKNOWLEDGMENTS
REFERENCES
Table 1.
Table 2.
All (n=21) |
Old female adult groups (n=17) |
|||
---|---|---|---|---|
Young-old, 65–74 yr (n=8) | Old-old, ≥75 yr (n=9) | p-value | ||
Age (yr) | 75.0±7.8 (52–88) | 70.8±2.4 (66–74) | 79.6±3.1 (75–86) | - |
Sex, female | 18 (85.7) | - | - | - |
Height (cm) | 154.26±6.04 (141.6–166.9) | 154.73±5.02 (146.4–160.6) | 151.13±5.43 (141.6–157.8) | 0.236f) |
Body mass (k) | 59.55±11.29 (37.5–80.1) | 66.51±11.00 (45.5–80.1) | 52.16±9.41 (37.5–64.6) | 0.006f) |
BMI (kg/m2) | 24.88±3.74 (18.7–31.1) | 27.69±3.64 (19.3–31.1) | 22.69±3.07 (18.7–27.3) | 0.006f) |
Waist circumference (cm) | 86.7±11.0 (68–109) | 92.88±11.09 (70–109) | 80.44±9.18 (68–94) | 0.018f) |
Resting SBP (mmHg) | 130.5±12.6 (105–150) | 129.3±9.0 (117–140) | 126.0±14.3 (105–145) | 0.773f) |
Resting DBP (mmHg) | 73.2±11.2 (49–92) | 78.8±6.9 (70–89) | 68.1±12.9 (49–92) | 0.038f) |
Resting HR (bpm) | 75.0±6.8 (67–90) | 74.8±6.8 (67–85) | 77.1±7.9 (68–90) | 0.630f) |
Myocardial infarction | 1 (6.3) | 1 (12.5) | 0 (0) | 0.274g) |
Diabetes mellitus | 10 (47.6) | 3 (37.5) | 5 (55.6) | 0.457h) |
Risk factors | ||||
Agea) | 20 (95.2) | 8 (100) | 9 (100) | |
Obesityb) | 12 (57.1) | 7 (87.5) | 4 (44.4) | |
Hypertension | 16 (76.2) | 5 (62.5) | 7 (77.8) | |
Dyslipidemiac) | 11 (52.4) | 3 (37.5) | 6 (66.7) | |
Prediabetesd) | 4 (19) | 2 (25) | 1 (11.1) | |
High HDL-Ce) | 4 (19) | 1 (12.5) | 3 (33.3) | |
Number of risk factors | 2.81±0.93 (1–5) | 3.00±0.93 (2–5) | 2.69±1.00 (1–4) | 0.606f) |
Values are presented as mean±standard deviation (range) or number (%).
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; HDL-C, high-density lipoprotein cholesterol.
Table 3.
T0 | T1 | T2 | Fa) | p-value |
p-value of post hocb) |
|||
---|---|---|---|---|---|---|---|---|
T0–T1 | T0–T2 | T1–T2 | ||||||
BMI (kg/m2) | 24.88±3.74 | 24.58±3.72 | 24.56±3.75 | 7.800 | 0.001 | 0.006 | 0.003 | 0.974 |
SBP (mmHg) | 130.5±12.6 | 128.9±10.3 | 128.4±7.6 | 0.271 | 0.764 | - | - | - |
Fasting blood sugar (mg/dL) | 127.7±26.7 | 115±21.3 | 106.8±13.0 | 13.400 | <0.001c) | 0.009 | <0.001 | 0.120 |
HbA1c (%) | 7.15±1.39 | 7.00±1.04 | 6.73±1.24 | 2.150 | 0.130 | - | - | - |
Total cholesterol (mg/dL) | 161.8±41.5 | 178.9±50.3 | 168.0±53.3 | 4.350 | 0.020 | 0.016 | 0.547 | 0.164 |
LDL-C (mg/dL) | 85.8±37.0 | 88.7±41.5 | 85.4±39.3 | 0.173 | 0.842 | - | - | - |
HDL-C (mg/dL) | 51.7±17.4 | 55.7±13.6 | 53.1±15.0 | 1.920 | 0.160 | - | - | - |
Triglyceride (mg/dL) | 119.4±83.1 | 157.8±82.2 | 125.1±59.0 | 2.660 | 0.082 | - | - | - |
EQ-5D-3L index | 0.868±0.084 | 0.862±0.074 | 0.881±0.079 | 0.930 | 0.403 | - | - | - |
IPAQ (MET-minute per week) | 1,596.8±1,044.5 | 2,568.9±1,572.5 | 2,366.1±1,489.5 | 3.150 | 0.054 | - | - | - |
KASI score | 42.4±12.36 | 48.23±11.98 | 49.01±11.04 | 3.120 | 0.055 | - | - | - |
6MWD (m) | 461.25±39.43 | 498.41±45.44 | 520.44±53.34 | 25.100 | <0.001 | <0.001 | <0.001 | 0.033 |
Estimated VO2max (mL/kg/min) | 15.56±0.91 | 16.41±1.05 | 16.92±1.23 | 25.100 | <0.001 | <0.001 | <0.001 | 0.033 |
Values are presented as mean±standard deviation.
BMI, body mass index; SBP, systolic blood pressure; HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; EQ-5D-3L, the European Quality of Life-5 Dimension-3-Level version; IPAQ, the International Physical Activity Questionnaire; KASI, the Korean Activity Scale/Index; 6MWD, 6-minute walk distance.
Table 4.
T0 | T2 | p-valuea) | ΔT2–T0 | p-valueb) | |
---|---|---|---|---|---|
BMI (kg/m2) | 0.815 | ||||
Young | 27.7±1.29 | 27.5±1.31 | 0.195 | -0.24±0.14 | |
Old | 22.7±1.02 | 22.6±1.00 | 0.369 | -0.14±0.17 | |
Fasting blood sugar (mg/dL) | 0.962 | ||||
Young | 134.9±11.89 | 114.4±6.05 | 0.039 | -20.50±9.22 | |
Old | 123.4±6.87 | 104.3±2.35 | 0.015 | -19.11±6.24 | |
6MWD (m) | 0.277 | ||||
Young | 461.4±14.46 | 536.4±19.01 | 0.008 | 75.03±13.69 | |
Old | 461.2±14.91 | 519.9±16.48 | 0.008 | 58.77±11.86 |